Goodbye to Migraines? Famous University Makes a Revolutionary Discovery

A study by scientists sheds new light on the causes of migraines and opens up new treatment options.

A migraine can ruin even the best day for anyone. What's especially annoying is that we often don't even know what's causing the headache. Is it the weather, fatigue, stress, or maybe something serious? Anyway, whatever the reason, it is a highly unpleasant feeling that can put you into bed for a day, a week, or even longer, and nothing would help. However, there are some good news coming from recent studies. 

Migraines are difficult to diagnose and treat because scientists, until now, have not known exactly what causes them. A recent discovery by a team at the University of Rochester in New York gives us hope that we may finally be able to identify the causes of these intense headaches.

According to the results of this study, so-called "auras" — flashes of light that create blind spots in a person's field of vision—precede a significant proportion of migraine episodes. Until now, their connection to migraines was unclear, but scientists have now discovered that these auras are caused by the movement of cerebrospinal fluid flowing around the brain. This movement releases certain proteins that interact with nerves, causing headaches.

Researchers have identified twelve types of proteins that double their concentration during the appearance of an aura, including CGRP, a peptide associated with pain transmission. This discovery opens the door to new and more effective treatments. By targeting this protein, it will be possible to treat the cause of the migraine and not just its symptoms, as conventional drugs do. "These findings will provide new targets for inhibiting sensory nerve activation, allowing us to prevent and treat migraines while improving existing treatments," the study's authors conclude in an article published in the "Science" magazine.

How soon will we have an effective way to treat the causes of migraines? The scientists' discoveries must be followed by clinical trials, which are necessary to ensure patient safety and introduce new therapies into medical practice.